N-803 (IL-15 Superagonist)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Assess Anktiva in Patients With Long Covid-19.NCT07108036IBRXPhase 2Recruiting2026-10Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.